loadpatents
name:-0.033507108688354
name:-0.023390054702759
name:-0.0048708915710449
JURKAUSKAS; Valdas Patent Filings

JURKAUSKAS; Valdas

Patent Applications and Registrations

Patent applications and USPTO patent grants for JURKAUSKAS; Valdas.The latest application filed is for "lipoxin a4 analogs and uses thereof".

Company Profile
4.25.31
  • JURKAUSKAS; Valdas - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lipoxin A4 Analogs And Uses Thereof
App 20210401798 - CHIANG; Nan ;   et al.
2021-12-30
Methods And Compositions Relating To Ultrapure 5-(1,1-dimethylheptyl)-resorcinol
App 20210198223 - JURKAUSKAS; Valdas ;   et al.
2021-07-01
Intermediates in the synthesis of cephalosporin compounds
Grant 10,941,161 - Moshos , et al. March 9, 2
2021-03-09
Intermediates In The Synthesis Of Cephalosporin Compounds
App 20190225624 - Moshos; Kristos Adrian ;   et al.
2019-07-25
7-aminocephem derivative compounds
Grant 10,308,666 - Moshos , et al.
2019-06-04
Intermediates in the synthesis of cephalosporin compounds
Grant 10,221,196 - Moshos , et al.
2019-03-05
Synthesis of cephalosporin compounds
Grant 10,214,543 - Moshos , et al. Feb
2019-02-26
7-aminocephem Derivative Compounds
App 20180258101 - MOSHOS; Kristos Adrian ;   et al.
2018-09-13
Thiadiazolyl-oximinoacetic acid derivative compounds
Grant 10,059,680 - Moshos , et al. August 28, 2
2018-08-28
Pyrazolyl carboxylic acid and pyrazolyl urea derivative compounds
Grant 10,035,774 - Moshos , et al. July 31, 2
2018-07-31
Synthesis Of Cephalosporin Compounds
App 20180170949 - MOSHOS; Kristos Adrian ;   et al.
2018-06-21
Salt forms of ceftolozane
Grant 10,000,510 - Gu , et al. June 19, 2
2018-06-19
Thiadiazolyl - Oximinoacetic Acid Derivative Compounds
App 20170369459 - Moshos; Kristos Adrian ;   et al.
2017-12-28
Pyrazolyl Carboxylic Acid And Pyrazolyl Urea Derivative Compounds
App 20170362183 - Moshos; Kristos Adrian ;   et al.
2017-12-21
Inhibitors of influenza viruses replication
Grant 9,771,361 - Nti-Addae , et al. September 26, 2
2017-09-26
Salt Forms Of Ceftolozane
App 20170233408 - Gu; Jian-Qiao ;   et al.
2017-08-17
Intermediates In The Synthesis Of Cephalosporin Compounds
App 20170226126 - Moshos; Kristos Adrian ;   et al.
2017-08-10
Reactions of thiadiazolyl-oximinoacetic acid derivative compounds
Grant 9,695,196 - Moshos , et al. July 4, 2
2017-07-04
Inhibitors Of Influenza Viruses Replication
App 20160251353 - Nti-Addae; Kwame W. ;   et al.
2016-09-01
Solid Forms of Ceftolozane
App 20160228448 - Hwang; You Seok ;   et al.
2016-08-11
7-aminocephem Derivative Compounds
App 20160176897 - MOSHOS; Kristos Adrian ;   et al.
2016-06-23
Tazobactam Arginine Antibiotic Compositions
App 20150306076 - Lai; Jan-Ji ;   et al.
2015-10-29
Solid Forms Of Ceftolozane
App 20150094293 - Jurkauskas; Valdas ;   et al.
2015-04-02
Tazobactam Arginine Compositions
App 20150072957 - Lai; Jan-Ji ;   et al.
2015-03-12
Solid forms of ceftolozane
Grant 8,906,898 - Hwang , et al. December 9, 2
2014-12-09
Processes and intermediates
Grant 8,871,904 - Tanoury , et al. October 28, 2
2014-10-28
Tazobactam Arginine Compositions
App 20140228337 - Lai; Jan-Ji ;   et al.
2014-08-14
Tazobactam Arginine Antibiotic Compositions
App 20140213567 - Lai; Jan-Ji ;   et al.
2014-07-31
Tazobactam Arginine Antibiotic Compositions
App 20140206659 - Lai; Jan-Ji ;   et al.
2014-07-24
Methods For Preparation Of Thiophene Compounds
App 20140206888 - Jurkauskas; Valdas ;   et al.
2014-07-24
Tazobactam Arginine Antibiotic Compositions
App 20140187528 - Lai; Jan-Ji ;   et al.
2014-07-03
Co-crystals and pharmaceutical compositions comprising the same
Grant 8,759,353 - Connelly , et al. June 24, 2
2014-06-24
Processes And Intermediates
App 20140107318 - Tanoury; Gerald J. ;   et al.
2014-04-17
Tazobactam arginine compositions
Grant 8,685,957 - Lai , et al. April 1, 2
2014-04-01
Tazobactam Arginine Compositions
App 20140088067 - Lai; Jan-Ji ;   et al.
2014-03-27
Processes and intermediates
Grant 8,637,457 - Tanoury , et al. January 28, 2
2014-01-28
Co-crystals and pharmaceutical formulations comprising the same
Grant 8,541,025 - Dokou , et al. September 24, 2
2013-09-24
Processes And Intermediates
App 20130172276 - TANOURY; GERALD J. ;   et al.
2013-07-04
Tazobactam arginine compositions
Grant 8,476,425 - Lai , et al. July 2, 2
2013-07-02
Processes and intermediates
Grant 8,399,615 - Tanoury , et al. March 19, 2
2013-03-19
Co-crystals And Pharmaceutical Formulations Comprising The Same
App 20110236478 - Dokou; Eleni ;   et al.
2011-09-29
Co-Crystals and Pharmaceutical Compositions Comprising the Same
App 20110059987 - Connelly; Patrick R. ;   et al.
2011-03-10
Processes and intermediates
Grant 7,776,887 - Tanoury , et al. August 17, 2
2010-08-17
Processes and intermediates
App 20100174077 - Tanoury; Gerald J. ;   et al.
2010-07-08
Processes And Intermediates
App 20100063252 - Tanoury; Gerald J. ;   et al.
2010-03-11
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
App 20050065349 - Buchwald, Stephen L. ;   et al.
2005-03-24
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
Grant 6,787,655 - Buchwald , et al. September 7, 2
2004-09-07
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
App 20030125563 - Buchwald, Stephen L. ;   et al.
2003-07-03
Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
Grant 6,465,664 - Buchwald , et al. October 15, 2
2002-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed